title: Inhibitory effect of bFGF on endochondral heterotopic ossification.
abstract: Basic fibroblast growth factor (bFGF) is reported to stimulate repair of fracture and bony defects in in vivo animal studies. However, most studies performed in vitro demonstrate inhibitory effect of bFGF on cartilage and bone differentiation. To understand the discrepancy observed in in vivo and in vitro studies, we evaluated the effect of bFGF on chondro-osteogenesis initiated by bone matrix powder (MP). MP was implanted in the murine hamstring muscles with or without administration of bFGF. Injection of 1 microg of bFGF markedly reduced the size of heterotopic bone induced by MP, as detected by X-ray. Injection of 10 microg of bFGF completely inhibited ossification and only fibrous tissues were observed at the site of MP implantation. The expressions of alkaline phosphatase and osteocalcin mRNAs, markers for bone differentiation, were completely suppressed by 10 microg of bFGF. These results demonstrate the inhibitory effect of bFGF on endochondral ossification in vivo, implicating a precaution for its use in musculo-skeletal disorders.
authors.affiliation: Department of Orthopaedic Surgery, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. sakanos@med.nagoya-u.ac.jp
authors.forename: Shinji
authors.initials: S
authors.lastname: Sakano
authors.forename: Yukiharu
authors.initials: Y
authors.lastname: Hasegawa
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Murata
authors.forename: Takayasu
authors.initials: T
authors.lastname: Ito
authors.forename: Eiichi
authors.initials: E
authors.lastname: Genda
authors.forename: Hisashi
authors.initials: H
authors.lastname: Iwata
authors.forename: Naoki
authors.initials: N
authors.lastname: Ishiguro
authors.forename: Hisao
authors.initials: H
authors.lastname: Seo
mesh_terms: D000469:Alkaline Phosphatase / Q000096:biosynthesis / Q000235:genetics; D000818:Animals; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009999:Ossification, Heterotopic / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D015675:Osteocalcin / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D011859:Radiography
chemical_list: D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2; D015675:Osteocalcin; D000469:Alkaline Phosphatase